LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort

Journal of Proteome Research

Volumn 11, Issue 12, 2012, Pages 5914-5923

  Xiao, Jun Feng ^a   Varghese, Rency S ^a   Zhou, Bin ^a   Nezami Ranjbar, Mohammad R ^a   Zhao, Yi ^a   Tsai, Tsung Heng ^a   Di Poto, Cristina ^a   Wang, Jinlian ^a   Goerlitz, David ^a   Luo, Yue ^a   Cheema, Amrita K ^a   Sarhan, Naglaa ^c   Soliman, Hanan ^c   Tadesse, Mahlet G ^b   Ziada, Dina Hazem ^c   Ressom, Habtom W ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c TANTA UNIVERSITY   (Egypt)

Author keywords

cancer biomarker discovery; hepatocellular carcinoma; isotope dilution; liver cirrhosis; mass spectrometry; metabolic biomarker; selected reaction monitoring

Indexed keywords

3BETA, 6BETA DIHYDROXY 5BETA CHOLAN 24 OIC ACID; BILE ACID; BIOLOGICAL MARKER; CARNITINE; GLYCHOLIC ACID; GLYCODEOXYCHOLIC ACID; OLEOYL CARNITINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EGYPT; FEMALE; FRAGMENTATION REACTION; HUMAN; ISOTOPE DILUTION ASSAY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; METABOLITE; METABOLOMICS; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; QUADRUPOLE TIME OF FLIGHT MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; COMPUTATIONAL BIOLOGY; EGYPT; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; NEOPLASM STAGING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84870915868     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr300673x     Document Type: Article

References (34)

1. Reuben, A. The crab, the turkey and a malignant tale from the year of the rooster Hepatology 2005, 41 (4) 944-950
2. Taketa, K. α-Fetoprotein: Reevaluation in hepatology Hepatology 1990, 12 (6) 1420-1432
3. Soliman, H. H.; Nagy, H.; Kotb, N.; Alm El-Din, M. A. The role of chemokine CC ligand 20 in patients with liver cirrhosis and hepatocellular carcinoma Int. J. Biol. Markers 2012, 27 (2) e125-e131
4. Fiehn, O. Metabolomics-The link between genotypes and phenotypes Plant Mol. Biol. 2002, 48 (1) 155-171
5. Nicholson, J. K.; Lindon, J. C.; Holmes, E. Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 1999, 29 (11) 1181-1189
6. Madsen, R.; Lundstedt, T.; Trygg, J. Chemometrics in metabolomics-A review in human disease diagnosis Anal. Chim. Acta 2010, 659 (1-2) 23-33
7. Li, M.; Wang, B.; Zhang, M.; Rantalainen, M.; Wang, S.; Zhou, H.; Zhang, Y.; Shen, J.; Pang, X.; Zhang, M.; Wei, H.; Chen, Y.; Lu, H.; Zuo, J.; Su, M.; Qiu, Y.; Jia, W.; Xiao, C.; Smith, L. M.; Yang, S.; Holmes, E.; Tang, H.; Zhao, G.; Nicholson, J. K.; Li, L.; Zhao, L. Symbiotic gut microbes modulate human metabolic phenotypes Proc. Natl. Acad. Sci. U.S.A. 2008, 105 (6) 2117-2122
8. Xiao, J. F.; Zhou, B.; Ressom, H. W. Metabolite identification and quantitation in LC-MS/MS-based metabolomics Trends Anal. Chem. 2012, 32 (0) 1-14
9. Zhou, B.; Xiao, J. F.; Tuli, L.; Ressom, H. W. LC-MS-based metabolomics Mol. BioSyst. 2012, 8, 470-481
10. Wang, B.; Chen, D.; Chen, Y.; Hu, Z.; Cao, M.; Xie, Q.; Chen, Y.; Xu, J.; Zheng, S.; Li, L. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry J. Proteome Res. 2012, 11 (2) 1217-1227
11. Tan, Y.; Yin, P.; Tang, L.; Xing, W.; Huang, Q.; Cao, D.; Zhao, X.; Wang, W.; Lu, X.; Xu, Z.; Wang, H.; Xu, G. Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis Mol. Cell. Proteomics 2012, 11 (2 M111.010694
12. Chen, T.; Xie, G.; Wang, X.; Fan, J.; Qiu, Y.; Zheng, X.; Qi, X.; Cao, Y.; Su, M.; Wang, X.; Xu, L. X.; Yen, Y.; Liu, P.; Jia, W. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma Mol. Cell. Proteomics 2011, 10 (7 M110.004945
13. Chen, J.; Wang, W.; Lv, S.; Yin, P.; Zhao, X.; Lu, X.; Zhang, F.; Xu, G. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations Anal. Chim. Acta 2009, 650 (1) 3-9
14. Yang, J.; Zhao, X.; Liu, X.; Wang, C.; Gao, P.; Wang, J.; Li, L.; Gu, J.; Yang, S.; Xu, G. High performance liquid chromatography mass spectrometry for metabonomics: Potential biomarkers for acute deterioration of liver function in chronic hepatitis B J. Proteome Res. 2006, 5 (3) 554-561
15. Yin, P.; Wan, D.; Zhao, C.; Chen, J.; Zhao, X.; Wang, W.; Lu, X.; Yang, S.; Gu, J.; Xu, G. A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry Mol. BioSyst. 2009, 5 (8) 868-876
16. Patterson, A. D.; Maurhofer, O.; Beyoglu, D.; Lanz, C.; Krausz, K. W.; Pabst, T.; Gonzalez, F. J.; Dufour, J.-F. o.; Idle, J. R. Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling Cancer Res. 2011, 71 (21) 6590-6600
17. Dunn, W. B.; Broadhurst, D.; Begley, P.; Zelena, E.; Francis-McIntyre, S.; Anderson, N.; Brown, M.; Knowles, J. D.; Halsall, A.; Haselden, J. N.; Nicholls, A. W.; Wilson, I. D.; Kell, D. B.; Goodacre, R. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry Nat. Protoc. 2011, 6 (7) 1060-1083
18. Tautenhahn, R.; Böttcher, C.; Neumann, S., Annotation of LC/ESI-MS Mass Signals. In Bioinformatics Research and Development; Hochreiter, S.; Wagner, R., Eds.; Springer: Berlin/Heidelberg, 2007; Vol. 4414, pp 371-380.
19. Storey, J. D. A direct approach to false discovery rates J. R. Stat. Soc., Ser. B 2002, 64 (3) 479-498
20. Zhou, B.; Wang, J.; Ressom, H. MetaboSearch: Tool for mass-based metabolite identification using multiple databases PLoS One 2012, 7 (6 e40096
21. Wishart, D. S.; Tzur, D.; Knox, C.; Eisner, R.; Guo, A. C.; Young, N.; Cheng, D.; Jewell, K.; Arndt, D.; Sawhney, S.; Fung, C.; Nikolai, L.; Lewis, M.; Coutouly, M.-A.; Forsythe, I.; Tang, P.; Shrivastava, S.; Jeroncic, K.; Stothard, P.; Amegbey, G.; Block, D.; Hau, D. D.; Wagner, J.; Miniaci, J.; Clements, M.; Gebremedhin, M.; Guo, N.; Zhang, Y.; Duggan, G. E.; MacInnis, G. D.; Weljie, A. M.; Dowlatabadi, R.; Bamforth, F.; Clive, D.; Greiner, R.; Li, L.; Marrie, T.; Sykes, B. D.; Vogel, H. J.; Querengesser, L. HMDB: the Human Metabolome Database Nucleic Acids Res. 2007, 35 (Suppl 1) D521-D526
22. Smith, C. A.; Maille, G. O.; Want, E. J.; Qin, C.; Trauger, S. A.; Brandon, T. R.; Custodio, D. E.; Abagyan, R.; Siuzdak, G. METLIN: A Metabolite Mass Spectral Database Ther. Drug Monit. 2005, 27 (6) 747-751
23. Cui, Q.; Lewis, I. A.; Hegeman, A. D.; Anderson, M. E.; Li, J.; Schulte, C. F.; Westler, W. M.; Eghbalnia, H. R.; Sussman, M. R.; Markley, J. L. Metabolite identification via the Madison Metabolomics Consortium Database Nat. Biotechnol. 2008, 26 (2) 162-164
24. Fahy, E.; Sud, M.; Cotter, D.; Subramaniam, S. LIPID MAPS online tools for lipid research Nucleic Acids Res. 2007, 35 (Suppl 2) W606-W612
25. Ressom, H.; Xiao, J.; Tuli, L.; RS, V.; Zhou, B.; Tsai, T.; Ranjbar, M.; Zhao, Y.; Wang, J.; Poto, C.; Cheema, A.; Tadesse, M.; Goldman, R.; Shetty, K. Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis Anal. Chim. Acta 2012, 743, 90-100
26. Goto, T.; Myint, K. T.; Sato, K.; Wada, O.; Kakiyama, G.; Iida, T.; Hishinuma, T.; Mano, N.; Goto, J. LC/ESI-tandem mass spectrometric determination of bile acid 3-sulfates in human urine: 3β;-Sulfooxy-12α-hydroxy- 5β;-cholanoic acid is an abundant nonamidated sulfate J. Chromatogr., B 2007, 846 (1-2) 69-77
27. Watanabe, M.; Houten, S. M.; Mataki, C.; Christoffolete, M. A.; Kim, B. W.; Sato, H.; Messaddeq, N.; Harney, J. W.; Ezaki, O.; Kodama, T.; Schoonjans, K.; Bianco, A. C.; Auwerx, J. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation Nature 2006, 439 (7075) 484-489
28. Gowda, G. A. N. Human bile as a rich source of biomarkers for hepatopancreatobiliary cancers Biomarkers Med. 2010, 4 (2) 299-314
29. Etzioni, A.; Levy, J.; Nitzan, M.; Erde, P.; Benderly, A. Systemic carnitine deficiency exacerbated by a strict vegetarian diet Arch. Dis. Child. 1984, 59 (2) 177-179
30. Bremer, J. Carnitine-Metabolism and functions Physiol. Rev. 1983, 63 (4) 1420-1480
31. Chan, W.; Lin, S.; Sun, S.; Liu, H.; Luk, J.; Cai, Z. Metabolomics analysis of the responses to partial hepatectomy in hepatocellular carcinoma patients Am. J. Anal. Chem. 2011, 2 (2) 142-151
32. Zhou, L.; Wang, Q.; Yin, P.; Xing, W.; Wu, Z.; Chen, S.; Lu, X.; Zhang, Y.; Lin, X.; Xu, G. Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases Anal. Bioanal. Chem. 2012, 403 (1) 203-213
33. Hanahan, D.; Weinberg, R. A. Hallmarks of cancer: The next generation Cell 2011, 144 (5) 646-674
34. Tessitore, L.; Marengo, B.; Vance, D. E.; Papotti, M.; Mussa, A.; Daidone, M. G.; Costa, A. Expression of phosphatidylethanolamine N-methyltransferase in human hepatocellular carcinomas Oncology 2003, 65 (2) 152-158